loxapine has been researched along with Autism Spectrum Disorder in 5 studies
Loxapine: An antipsychotic agent used in SCHIZOPHRENIA.
Autism Spectrum Disorder: Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our clinical experience with low dose loxapine (5-15 mg/day) suggests promising efficacy and safety for irritability in autism spectrum disorders (ASD)." | 9.20 | Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. ( Aman, MG; Andridge, R; Barth, FX; Butler, MG; Cain, SE; Han, JC; Hellings, JA; Logan, M; Mikhnev, D; Palaguachi, GI; Reed, G; Teng, R; Zhou, X, 2015) |
| " Data were also then retrospectively extracted from clinic charts regarding age, gender, diagnoses, LOX doses, treatment duration, concomitant medications, and LOX dosage reductions." | 5.42 | Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders. ( Genovese, A; Hellings, JA; Jadhav, M; Jadhav, S; Jain, S, 2015) |
| "Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness." | 3.83 | Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review. ( Andridge, R; Hellings, JA; Jain, S, 2016) |
| " Data were also then retrospectively extracted from clinic charts regarding age, gender, diagnoses, LOX doses, treatment duration, concomitant medications, and LOX dosage reductions." | 1.42 | Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders. ( Genovese, A; Hellings, JA; Jadhav, M; Jadhav, S; Jain, S, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garel, N | 1 |
| Joober, R | 1 |
| Hellings, JA | 4 |
| Arnold, LE | 1 |
| Han, JC | 2 |
| Reed, G | 1 |
| Cain, SE | 1 |
| Zhou, X | 1 |
| Barth, FX | 1 |
| Aman, MG | 1 |
| Palaguachi, GI | 1 |
| Mikhnev, D | 1 |
| Teng, R | 1 |
| Andridge, R | 2 |
| Logan, M | 1 |
| Butler, MG | 1 |
| Jadhav, M | 1 |
| Jain, S | 2 |
| Jadhav, S | 1 |
| Genovese, A | 1 |
1 review available for loxapine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.
Topics: Adolescent; Adult; Amitriptyline; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; Brai | 2017 |
1 trial available for loxapine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.
Topics: Adolescent; Adult; Antipsychotic Agents; Autism Spectrum Disorder; Brain-Derived Neurotrophic Factor | 2015 |
3 other studies available for loxapine and Autism Spectrum Disorder
| Article | Year |
|---|---|
Treatment of first-episode psychosis in patients with autism-spectrum disorder and intellectual deficiency
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Autism Spectrum Disorder; D | 2019 |
Low Dose Loxapine: Neuromotor Side Effects and Tolerability in Autism Spectrum Disorders.
Topics: Adolescent; Adult; Akathisia, Drug-Induced; Autism Spectrum Disorder; Child; Cross-Sectional Studies | 2015 |
Loxapine for Reversal of Antipsychotic-Induced Metabolic Disturbances: A Chart Review.
Topics: Adolescent; Adult; Antipsychotic Agents; Autism Spectrum Disorder; Female; Humans; Irritable Mood; L | 2016 |